OrbiMed Capital GP VII LLC, 10% Owner at Passage BIO, Inc. (PASG), bought 525,000 shares at $1.93 ($1.0M) on 2022-05-03, disclosed to the SEC on 2022-05-05.
Open-market purchase of $1.0M PASG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.93 | 221,500 | $427K | 42.1% |
| 2 | $1.94 | 303,500 | $589K | 57.9% |
| Total | $1.94 avg | 525,000 | $1.0M | 100% |
| Filing → |
| PASG | SELL | 2024-12-26 | $276K | — | Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |